esophageal cancer
Conditions
Interventions
orally taking pancrelipase terms: three months amounts: 600mg/meal times: ever time after meal
Sponsors
Kobe University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Esophageal cancer patients who is after esophagectomy and coming for follow-up visit. 2) Patients with lower fecal elastase1 than 200mg/g and has higher Bristol scale than 6. 3) Patients who had got informed consent.
Exclusion criteria
Exclusion criteria: 1)Patients who is treating by chemotherapy or radiotherapy. 2)Patients who are allergic to swine protein. 3)Patients who had over 5kg of weight movement. 4)Patients who has a possibility of pregnant or now pregnant, or while nursing. 5)Patients with severe infection. 6)Patients who did not give consent to this research. 7)Patients who are suspected of chronic pancreatitis, after pancreatectomy and other cause of exocrine pancreatic dysfunction. 8)Patients with dyschezia caused by irritable bowel syndrome or inflammatory bowel disease. 9)Patients treated by enteral alimentation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of frequency of the stool below two times a day. The ratio of bristol scale below 4. | — |
Countries
Japan
Contacts
Public ContactTetsu Nakamura
Kobe University Division of Gastrointestinal Surgery
Outcome results
None listed